Trials / Unknown
UnknownNCT02734329
Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 15 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Zero ischemia laparoscopic radio frequency ablation assisted tumor enucleation has been proved to enable tumor excision with relatively better renal function preservation comparing with conventional laparoscopic partial nephrectomy for T1a renal cell carcinoma (RCC) in a randomized clinical trial in single center. The investigators want to explore this technique to T1 RCC patients in randomized clinical trial in multiple centers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | conventional laparoscopic partial nephrectomy | renal artery will be clamped during surgery. |
| PROCEDURE | zero ischemia laparoscopic RFA/MVA assisted tumor enucleation (TE) |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2020-09-01
- First posted
- 2016-04-12
- Last updated
- 2016-05-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02734329. Inclusion in this directory is not an endorsement.